Back to News
Market Impact: 0.2
Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a Bet
Source: zacks.com
Analyst InsightsAnalyst EstimatesHealthcare & Biotech
Wall Street analysts’ average price target implies 75.6% potential upside for Vaxcyte (PCVX), though the article cautions that price targets may be a questionable indicator. Positive earnings-estimate revisions could support upside, but no specific revisions, target price, or market reaction are reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
PCVX0.30
More News
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- AI infrastructure stocks tumble. Here's a few reasons for the sell-off
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
- A second major Wall Street bank this week is telling clients to cash in tech stocks. Here's why
- Why Dell’s stock was one of the S&P 500’s biggest laggards on Wednesday
- These stocks offer some of the best risk-adjusted upside on Wall Street